Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry.
Penta B, Tang GHL, Abdel-Wahab M, Adrichem R, Ahmad H, Andreas M, Asgar AW, Belluschi I, Ben-Ali W, Bhadra O, Cheung A, Colli A, Conradi L, Corona S, De Backer O, Denti P, Desai ND, Di Eusanio M, DiMaio JM, Forrest JK, Fukuhara S, Geirsson A, Goel SS, Goldberg JB, Hagl C, Herrmann HC, Hokken TW, Kempfert J, Kiefer P, Kleiman NS, Kliger CA, Mach M, Marin-Cuartas M, Meier D, Modine T, Petrossian G, Pirelli L, Ramlawi B, Robinson N, Rovin JD, Ruge H, Saha S, Schults CC, Shih E, Szerlip M, Taramasso M, Unbehaun A, Van Mieghem N, Vitanova K, Waksman R, Wang L, Webb JG, Wyler von Ballmoos M, Reardon MJ, Nazif TN, Leon MB, Mack MJ, Kaneko T, Bapat VN, Zaid S; EXPLANTORREDO-TAVR Registry Investigators.
Penta B, et al. Among authors: taramasso m.
Circ Cardiovasc Interv. 2026 Apr 15:e016068. doi: 10.1161/CIRCINTERVENTIONS.125.016068. Online ahead of print.
Circ Cardiovasc Interv. 2026.
PMID: 41983299